Tailoring therapeutic interventions for breast cancer patients
Posted on behalf of Ru Bains, assistant editor for Genome Medicine Breast cancer is the most common cancer in women worldwide, and it is the second most common… Read more »
Latest posts by Maria Hodges (see all)
- Tailoring therapeutic interventions for breast cancer patients - 25th October 2013
- Understanding HPV-positive carcinoma for better outcomes - 21st February 2013
- Genome Medicine announces 'Single cell analysis' special issue: call for papers - 15th February 2013
Understanding HPV-positive carcinoma for better outcomes
Head and neck cancer is the sixth most common cancer worldwide, and head and neck squamous cell carcinoma (HNSCC) is the most frequent form. Certain subtypes of… Read more »
Genome Medicine announces 'Single cell analysis' special issue: call for papers
Later this year, Genome Medicine will publish a special issue on the topic of Single cell analysis: into the clinic. This issue will highlight the rapid… Read more »
Side effects of prednisolone, an anti-inflammatory drug
Anti-inflammatory drugs are taken for many conditions including asthma, rheumatoid arthritis and colitis. The most common class of these drugs, glucocorticoids,… Read more »
Metabolomics podcast by Genome Medicine
To round off our series on the Metabolomics of disease, Genome Medicine’s Editor, Rebecca Furlong, talks to leading scientists Tim Veenstra, David Wishart and… Read more »
Two steps to detecting stroke risk in women taking hormone therapy
Debates rage over why multiple large-scale studies to uncover risk factors for stroke have so far explained only a tiny proportion of inherited stroke cases and… Read more »
Call for papers: Genome Medicine announces a series on Pharmacogenomics
Efforts to predict and monitor drug response in individuals and in the population have increased markedly over the past few years, but there is a need for… Read more »
An interactive introduction to metabolomics
What is metabolomics and how is it being used to predict and manage disease? That’s the subject of Genome Medicine‘s and BioMed Central’s first… Read more »
DNA methylation of drug transporter gene might explain chemoresistance in liver cancer
Hepatocellular carcinoma is the third highest cause of cancer-related death world-wide. Although several treatments are available – and many more are… Read more »
November highlights from Genome Medicine: miRNA as a biomarker, RNA-seq, diabetes and more
November’s issueof Genome Medicine reflects the excitement in the field about the potential for RNA to act as a biomarker for disease and to help researchers… Read more »